Nucleoside Phosphoramidate Prodrugs
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application 60/909,315, filed Mar 30, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,334,270 | Nucleoside Phosphoramidate Prodrugs In force · Low confidence | Gilead Sciences, Inc. | In force | Low confidence | ||
| US 8,580,765 | Nucleoside Phosphoramidate Prodrugs In force · Low confidence | Gilead Sciences, Inc. | In force | Low confidence | ||
| US 8,735,372 | Nucleoside Phosphoramidate Prodrugs In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | ||
| US 8,906,880 | Nucleoside Phosphoramidate Prodrugs In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | ||
| US 8,957,046 | Nucleoside Phosphoramidate Prodrugs In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | ||
| US 9,085,573 | Nucleoside Phosphoramidate Prodrugs In force · Low confidence | Gilead Sciences, Inc. | In force | Low confidence | ||
| US 9,585,906 | Nucleoside Phosphoramidate Prodrugs In force · Low confidence | Gilead Sciences, Inc. | In force | Low confidence | ||
| US 10,183,037 | Nucleoside Phosphoramidate Prodrugs In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | ||
| US 12,121,529 | Nucleoside Phosphoramidate Prodrugs In force · Low confidence | Gilead Sciences, Inc. | In force | Low confidence | ||
| US 11,642,361 | Nucleoside Phosphoramidate Prodrugs In force · Medium confidence | Gilead Pharmasset LLC | In force | Medium confidence | ||
| 3 more patents in this group · Pro | ||||||
10 of 13 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 13, including 9 expiring within the 18 months from Nov 15, 2026.
10 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.